25.97USD-4.70%Mkt Cap: 2.24B $P/E: —1d ago
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid …
Industry Peers
Health Information Services$32.06BUSDP/E 35.0
$13.38BUSDP/E 88.5
$9.62BUSD
$8.27BUSDP/E 37.0
$6.65BUSD
$5.65BUSD
$4.44BUSDP/E 34.6
$3.43BUSDP/E 160.1
$2.14BUSDP/E 106.8
$1.71BUSD
$1.41BUSD
$1.17BUSD
$1.13BUSD
$1.06BUSDP/E 52.0
$874.42MUSDP/E Infinity
$845.49MUSDP/E 43.2
$672.72MUSDP/E 68.1
$637.77MUSD
$581.77MUSDP/E 27.4
$584.81MUSD
$552.27MUSDP/E 13.1
$524.39MUSD
$516.62MUSD
$494.46MUSDP/E 56.3
$460.71MUSDP/E 25.8
$446.52MUSDP/E 25.4
$393.58MUSDP/E 90.5
$368.70MUSDP/E 45.6
$321.33MUSD
$230.81MUSDP/E 14.1
$224.12MUSDP/E 18.2
$217.63MUSD
$182.96MUSD
$156.35MUSDP/E 39.4
$168.48MUSD
$148.67MUSDP/E 29.6
$123.72MUSDP/E Infinity
$124.79MUSDP/E 18.5
$113.48MUSDP/E 25.4
$99.01MUSDP/E 17.9
$86.66MUSD
$65.63MUSDP/E 11.3
$62.29MUSDP/E 22.6
$57.34MUSD
$47.87MUSDP/E 57.6
$49.50MUSD
$40.55MUSDP/E 38.7
$39.14MUSD
$31.93MUSD
$26.93MUSDP/E 26.0
$22.91MUSDP/E 54.8
$20.17MUSD
$18.43MUSD
$12.99MUSD
$13.69MUSD
$12.35MUSD
$11.72MUSD
$9.78MUSDP/E 15.1
$6.67MUSD
$6.50MUSD
$5.63MUSD
$4.88MUSD
$3.78MUSDP/E Infinity
$3.83MUSDP/E 0.0
$3.40MUSD
$2.98MUSD
$2.70MUSD
$2.16MUSDP/E Infinity
$693.4KUSD
$548.9KUSDP/E 0.0
$282.6KUSD
—
—
—
EYES
Corgi Data & Surveillance ETF—P/E 30.8
CRY
GraniteShares YieldBOOST CRCL ETF—
Indicators:|
Key Statistics
Company
Market Cap2.24B $
Enterprise Value2.22B $
Revenue (TTM)191.42M $
Gross Profit135.20M $
Net Income (TTM)-116.79M $
Revenue/Share3.375 USD
Last Price25.97 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees843
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-98.24
PEG—
EV/EBITDA-33.01
EV/Revenue11.59
P/S11.70
P/B7.83
EPS (TTM)-3.09
EPS (Forward)-0.26
52W Range
20.1328% of range41.22
52W High41.22 USD
52W Low20.13 USD
Profitability
Gross Margin76.80%
Oper. Margin-41.88%
EBITDA Margin-35.10%
Profit Margin-66.35%
ROE-38.85%
ROA-32.49%
Growth
Revenue Growth41.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-54.02M $
CapEx (TTM)5.03M $
FCF Margin-25.42%
FCF Yield-2.17%
Net Debt-131.97M $
Net Debt/EBITDA1.96
Balance Sheet
Debt/Equity0.07
Current Ratio5.57
Quick Ratio5.10
Book Value/Sh3.318 USD
Cash/Share1.836 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)37.00 USD
Upside (mean)+42.5%
Target Range35.00 USD – 40.00 USD
$35.00+42.5% to mean$40.00
# Analysts7
Ownership
Shares Out.86.24M
Float66.35M
Insiders5.13%
Institutions79.22%
Short Interest
Short Ratio2.5d
Short % Float8.72%
Short % Out.6.00%
Shares Short5.18M
Short (prev mo.)3.64M
Technical
SMA 5029.93 (-13.2%)
SMA 20029.76 (-12.7%)
Beta—
S&P 52W Chg20.25%
Avg Vol (30d)1.75M
Avg Vol (10d)1.43M
Technical Indicators
RSI (14)39.5
MACD-1.3372
MACD Signal-0.8012
MACD Hist.-0.5360
BB Upper37.70 USD
BB Middle30.15 USD
BB Lower22.61 USD
BB Width50.05%
ATR (14)2.127 USD
Vol Ratio (20d)0.43x